ADNP | Activity-dependent neuroprotector homeobox | Cancer-related genes Transcription factors
| | | | | Expressed in all |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
BCL6 | B-cell CLL/lymphoma 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CNOT4 | CCR4-NOT transcription complex, subunit 4 | Transcription factors
| | | | | Expressed in all |
CTCF | CCCTC-binding factor (zinc finger protein) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CTCFL | CCCTC-binding factor (zinc finger protein)-like | Predicted membrane proteins Transcription factors
| | | | | Tissue enriched |
CXXC1 | CXXC finger protein 1 | Transcription factors
| | | | | Expressed in all |
DMRT1 | Doublesex and mab-3 related transcription factor 1 | Disease related genes Transcription factors
| | | | | Tissue enriched |
DMRTB1 | DMRT-like family B with proline-rich C-terminal, 1 | Transcription factors
| | | | | Tissue enriched |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
EGR3 | Early growth response 3 | Transcription factors
| | | | | Mixed |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GATAD2A | GATA zinc finger domain containing 2A | Plasma proteins Transcription factors
| | | | | Expressed in all |
GATAD2B | GATA zinc finger domain containing 2B | Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
GFI1 | Growth factor independent 1 transcription repressor | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GLI2 | GLI family zinc finger 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GLIS3 | GLIS family zinc finger 3 | Disease related genes Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
GTF3A | General transcription factor IIIA | Transcription factors
| | | | | Expressed in all |
HIVEP3 | Human immunodeficiency virus type I enhancer binding protein 3 | Transcription factors
| | | | | Mixed |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
KAT6B | K(lysine) acetyltransferase 6B | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
KDM2A | Lysine (K)-specific demethylase 2A | Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
KLF3 | Kruppel-like factor 3 (basic) | Transcription factors
| | | | | Expressed in all |
KLF4 | Kruppel-like factor 4 (gut) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KLF6 | Kruppel-like factor 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Transcription factors
| | | | | Expressed in all |
LYAR | Ly1 antibody reactive | Transcription factors
| | | | | Expressed in all |
MBD1 | Methyl-CpG binding domain protein 1 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MECOM | MDS1 and EVI1 complex locus | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
MTA1 | Metastasis associated 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MTA2 | Metastasis associated 1 family, member 2 | Plasma proteins Transcription factors
| | | | | Expressed in all |
MTF1 | Metal-regulatory transcription factor 1 | Transcription factors
| | | | | Expressed in all |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Transcription factors
| | | | | Tissue enriched |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
PEG3 | Paternally expressed 3 | Transcription factors
| | | | | Tissue enhanced |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Group enriched |
POGZ | Pogo transposable element with ZNF domain | Plasma proteins Transcription factors
| | | | | Expressed in all |
PRDM1 | PR domain containing 1, with ZNF domain | Cancer-related genes Transcription factors
| | | | | Mixed |
PRDM5 | PR domain containing 5 | Disease related genes Transcription factors
| | | | | Mixed |
RARB | Retinoic acid receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Mixed |
RARG | Retinoic acid receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Expressed in all |
REST | RE1-silencing transcription factor | Plasma proteins Transcription factors
| | | | | Expressed in all |